HIV-Associated TB in An Giang Province, Vietnam, 2001-2004: Epidemiology and TB Treatment Outcomes

PLoS ONE

Volumn 2, Issue 6, 2007, Pages

  Thuy, Trinh Thanh ^a   Shah, N Sarita ^a   Anh, Mai Hoang ^b   Nghia, Do Trong ^c   Thom, Duong ^b   Linh, Truong ^b   Sy, Dinh Ngoc ^c   Duong, Bui Duc ^c   Chau, Luu Thi Minh ^c   Mai, Phung Thi Phuong ^c   Wells, Charles D ^a   Laserson, Kayla F ^a   Varma, Jay K ^a,d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b An Giang Province Preventive Medical Center   (Viet Nam)

^c MINISTRY OF HEALTH   (Viet Nam)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; TUBERCULOSIS; VIET NAM;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; COHORT STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS; VIETNAM; YOUNG ADULT;

EID: 50849120433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000507     Document Type: Article

References (18)

1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al.(2003) The growing burden of tuberculosis: Global trends and interaction with the HIV epidemic. Arch Intern Med 163: 1009-1021.
2. World Health Organization(2006) Global tuberculosis control: surveillance, planning, financing. WHO report 2006 Geneva, Switzerland World Health Organization.
3. Apers L, Wijarajah C, Mutsvangwa J, Chigara N, Mason P, van der Stuyft, (2004) Accuracy of routine diagnosis of pulmonary tuberculosis in an area of high HIV prevalence. Int J Tuberc Lung Dis 8: 945-51.
4. Mukadi YD, Maher D, Harries A, (2001) Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 15: 143-52.
5. Dheda K, Lampe FC, Johnson MA, Lipman MC, (2004) Outcome of HIV-associated tuberculosis in the era of highly active anti-retroviral therapy. J Infect Dis 190: 1670-76.
6. Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, et al.(2002) Treatment of tuberculosis in HIV-infected persons in the era of highly active anti-retroviral therapy. AIDS 16: 75-83.
7. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, et al.(1999) Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial. Lancet 353: 1469-75.
8. Joint United Nations Programme on HIV/AIDS, (2006) Report on the global AIDS epidemic, 2006 Geneva, Switzerland UNAIDS.
9. Quy H, Cobelens F, Lan N, Buu T, Lambregts C, Borgdorff M, (2006) Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 10: 45-51.
10. World Health Organisation(2003) Treatment of tuberculosis: Guidelines for national programmes Geneva, Switzerland World Health Organization; 2003 Available at http://whqlibdoc.who.int/hq/2003/WHO_CDS_TB_2003.313_eng.pdf.
11. Mwaungulu FB, Floyd S, Crampin AC, Kasimba S, Malema S, et al.(2004) Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Bull WHO 82: 854-863.
12. Boeree MJ, Sauvageot D, Banda HT, Harries AD, Zijlstra EE, (2005) Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis. Trop Med and Int Health 10: 723-733.
13. Grimwade K, Sturm AW, Nunn AJ, Mbatha D, Zungu D, Gilks CF, (2005) Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa. AIDS 19: 163-168.
14. Grimwade K, Swingler G, (2004) Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV (Cochrane Review). The Cochrane Library, Issue 2, 2004 Chichester, UK John Wiley & Sons, Ltd.
15. World Health Organization(2004) Interim policy on collaborative TB/HIV activities Geneva, Switzerland World Health Organization (WHO/HTM/TB/2004.330) Available at http://whqlibdoc.who.int/hq/2004/who_htm_tb_2004.330.pdf.
16. Hargreaves NJ, Kadzakumanja O, Whitty CJ, Salaniponi FM, Harries AD, Squire SB, (2001) 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis 5: 847-54.
17. Freudenberg N, Fahs M, Galea S, Greenberg A, (2006) The impact of New York City's 1975 fiscal crisis on tuberculosis, HIV, and homicide syndemic. Am J Pub Health. 96: 424-434.
18. Tuan NA, Fylkesnes K, Thang BD, Hien NT, Long NT, et al.(2007) Human immunodeficiency virus (HIV) infection patterns and risk behaviours in different population groups and provinces in Viet Nam. Bull WHO 85: 35-41.